EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy

• Minhye Kim,
• Ji Min Na,
• Gyeong-Won Lee,
• Seung Jun Lee,
• Jong Duk Kim,
• Jung Wook Yang

Affiliations

Minhye Kim

Department of Pathology, Gyeonsang National University Hospital, Jinju, Korea

Ji Min Na

Department of Pathology, Gyeonsang National University Hospital, Jinju, Korea

Gyeong-Won Lee

Division of Hematology-Oncology, Department of Internal Medicine, Gyeonsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea

Seung Jun Lee

Division of Pulmonology and Allergy, Department of Internal Medicine, Gyeonsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea

Jong Duk Kim

Department of Cardiothoracic Surgery, Gyeonsang National University Hospital, Jinju, Korea

Jung Wook Yang

Department of Pathology, Gyeonsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea